相关实验视频
Updated: Feb 26, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
10.0K
抗topic疾病的IL-4Rα抑制剂
Howard Y Chang1, Kari C Nadeau1
1Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
Cell
|July 15, 2017
概括
杜皮卢马布是一种单克隆抗体,通过阻断关键的炎症细胞因子IL-4和IL-13有效治疗亚托皮炎. 这种向治疗为治疗湿疹提供了新的选择.
科学领域:
- 免疫学
- 皮肤病学
- 药理学
背景情况:
- 无菌性皮肤炎 (湿疹) 是一种由2型免疫反应驱动的慢性炎症性皮肤疾病.
- 干白素-4 (IL-4) 和干白素-13 (IL-13) 是调解2型炎症的关键细胞因子.
- 针对这些细胞因子提供了皮炎的潜在治疗策略.
研究的目的:
- 描述dupilumab,一种针对IL-4受体α子单元的新生物药物.
- 突出杜皮卢马布在阻断IL- 4和IL- 13信号的作用机制.
- 提供关于杜皮卢马布用于治疗亚托皮炎的批准和应用的信息.
主要方法:
- 杜皮卢马布是一种全人类单克隆抗体 (IgG4).
- 它特别针对IL-4和IL-13受体共享的α子单元 (IL-4Rα).
- 这种阻断抑制了这些关键细胞因子的下游信号通路.
主要成果:
- 杜皮卢马布有效抑制IL-4和IL-13信号通路.
- 这些通路对与亚托皮性皮肤炎相关的2型炎症反应至关重要.
- 已证明dupilumab在治疗阿托皮性皮肤炎中的临床疗效.
结论:
- 杜皮卢马布在治疗亚托皮炎方面取得了重大进展.
- 通过准2型炎症的关键驱动因素,它提供了有针对性的治疗方法.
- 杜皮卢马布的批准为中度至重度湿疹患者提供了一个新的生物选择.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K
T Cell Types and Functions
2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K

